Literature DB >> 305449

Control of human B lymphocyte responsiveness: enhanced suppressor T cell activity after in vitro incubation.

P E Lipsky, W W Ginsburg, F D Finkelman, M Ziff.   

Abstract

Human peripheral blood mononuclear cells (PBM) lost the capacity to generate immunoglobulin-secreting cells (ISC) in response to pokeweed mitogen (PWM) after a period of preincubation in vitro. When fresh PBM were co-cultured with preincubated PBM their response to PWM was inhibited, indicating that enhanced suppressor activity developed in the aged PBM concomitant with the loss of PWM responsiveness. Suppressor cell activity of aged PBM was present within the T lymphocyte population. The suppressor T cell inhibited PWM responsiveness of autologous and homologous PBM to an equivalent degree. The action of the suppressor cell was abrogated by inhibitors of DNA synthesis or by hydrocortisone. A suppressor T cell population with similar characteristics was found in freshly prepared PBM before in vitro incubation. Expansion of this suppressor T cell population during preincubation required cell division. There was no change in the functional capability of the helper T cell population as a result of similar in vitro culture. These observations indicate that a T cell population capable of suppressing PWM-induced generation of ISC can be selectively expanded by in vitro incubation of normal human PBM without additional mitogenic stimulation. Moreover, these data emphasize that control of B lymphocyte differentiation involves a critical interrelationship between T lymphocyte subpopulations exerting both positive and negative influences.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A.

Authors:  J B Innes; M M Kuntz; Y T Kim; M E Weksler
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

2.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Regulation of the primary in vitro antibody response in human peripheral blood lymphocytes: different effects of mitogen-induced and spontaneous T suppressor cells.

Authors:  P Galanaud; M C Crevon; J F Delfraissy; P Segond; C Wallon; J Dormont
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

4.  The regulation of T cell responses by spontaneously active suppressor cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 5.  Atopic allergy in relation to cell-mediated immunity.

Authors:  B Björkstén
Journal:  Clin Rev Allergy       Date:  1984-05

6.  Generation of suppressor cells in the autologous mixed lymphocyte reaction.

Authors:  P Fitzharris; R A Knight
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

7.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes.

Authors:  D A Cooper; M Duckett; P Hansen; V Petts; R Penny
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

8.  Characterization of a non-T, non-B human lymphocyte (L cell) with use of monoclonal antibodies. Its regulatory role in B lymphocyte function.

Authors:  P I Lobo
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

9.  In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.

Authors:  C Y Lin; C H Chen; P P Lee
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

10.  Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes.

Authors:  G C Bagby; J D Gabourel
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.